MARCOS
GONZÁLEZ DÍAZ
Investigador en el període 1993-2023
![Foto de MARCOS](/img/uploaded/ae5971d595dc15213a403ece497ea465.jpg)
![Foto de St. Joseph Medical Center](/img/noimage_org.png)
St. Joseph Medical Center
Houston, Estados UnidosPublicacions en col·laboració amb investigadors/es de St. Joseph Medical Center (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477